Welcome to the homepage of LBI-HTA !
The LBI-HTA is an acadmic non-profit institute and belongs to the Ludwig Boltzmann Society. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the LBI-HTA team.
Part I: Predictors, theories and models to explain and recommend courses of action to avoid discontinuation of therapy
Part II: "Overview of Reviews" on dropouts in psychotherapy
The project dealt in two parts with dropouts in psychotherapies. The first part of the report focused on definitions, parameters for describing psychotherapy dropouts and explanatory models. In addition, dropout predictors were identified at a meta-level, which were further empirically recorded in the second report part by an "Overview of systematic reviews". In this context, evidence synthesis (including 14 systematic reviews/meta-analyses) showed that a (young) age of psychotherapy patients and certain mental disorders (such as personality disorders) can represent relevant risk factors for an unplanned termination of psychotherapy. Dropout predictors, which are more likely to be attributed to psychotherapists, are currently only partially researched. With regard to suitable prevention strategies, eight measures were proposed in the report which, among other things, aimed at organisational aspects (e.g. clarification of therapy goals, possibilities and limits of psychotherapy) and interpersonal factors (e.g. strengthening the therapeutic alliance between patient and psychotherapist).
Publication: LBI-HTA Project report No. 100: http://eprints.hta.lbg.ac.at/1157/
Contact: Roman Winkler
We are pleased to introduce our two new HSO reports.
Tuesday, May 29th 2018, 9:00 AM to 5:30 PM
Gesellschaft der Ärzte
Frankgasse 8, 1090 Vienna
By invitation only
Philosophical Dialogue on 'Individual vs. collective benefit: Can the greatest possible benefit be calculated? Can the individual understand collective benefits?'
This Information is available in German only.
Screening for fetal trisomies 21, 18 and 13 by non-invasive prenatal testing (NIPT). EUnetHTA report
Since several years, numerous new non-invasive prenatal tests (NIPTs) have been available to identify common chromosomal anomalies. Most NIPTs are available for trisomies 21, 18 and 13 and sex chromosome aneuploidies, but many laboratories have expanded their range of analysis to include other trisomies and common microdeletions. The main advantage of NIPT compared to the conventional screening approach is the ease of implementation and non-invasiveness of the assay, as well as the potential reduction in false-positive [FP] results. An introduction of non-invasive genetic testing has ethical, social and organizational implications that need to be considered.
Publication: LBI-HTA Project report No. 103: http://eprints.hta.lbg.ac.at/1153/
Contact: Claudia Wild
We are pleased to introduce our new HSO report.